Showing results (901-910 of 2,107) with videos related to

Sort By:
Pageof 211
CNS Drugs|March 15, 2017
A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with AntipsychoticsYawen Jiang, Jeffrey S McCombs, Susie H Park
CNS Drugs|March 15, 2017
Statin Adherence and the Risk of Stroke: A Dose-Response Meta-AnalysisTao Xu, Xinyuan Yu, Shu Ou, et al.
CNS Drugs|August 16, 2019
Emerging Developments in Targeting Proteotoxicity in Neurodegenerative DiseasesLuke McAlary, Steven S Plotkin, Neil R Cashman
CNS Drugs|November 16, 2018
Opioidergic Agents as Antidepressants: Rationale and PromiseParnika P Saxena, J Alexander Bodkin
CNS Drugs|July 26, 2019
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release TabletsTina deVries, Angela Dentiste, Clifford Di Lea, et al.
CNS Drugs|March 14, 2008
Pregnancy outcome after in utero exposure to valproate : evidence of dose relationship in teratogenic effectOrna Diav-Citrin, Svetlana Shechtman, Benjamin Bar-Oz, et al.
CNS Drugs|April 2, 2014
Adenosine A2A receptor antagonists in Parkinson's disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinuedAnnalisa Pinna
CNS Drugs|April 1, 2014
A cross-sectional study on drug use in multiple system atrophyMaría Verónica Rey, Santiago Perez-Lloret, Anne Pavy-Le Traon, et al.
CNS Drugs|March 20, 2014
Birth outcomes in newborns fathered by men with multiple sclerosis exposed to disease-modifying drugsEllen Lu, Feng Zhu, Yinshan Zhao, et al.
CNS Drugs|December 13, 2007
The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implicationsQingguang Jiang, Michael Heneka, Gary E Landreth
Pageof 211